BioRestorative Therapies Inc BRTX:NASDAQ

RT Quote | Last NYSE Arca, VOL From CTA | USD
after hours iconAfter Hours: Last | 7:48 PM EDT
1.28quote price arrow up+0.01 (+0.79%)
Volume
9,640
Close
1.27quote price arrow down-0.07 (-5.22%)
Volume
74,682
52 week range
1.20 - 7.13
Loading...
  • Open1.35
  • Day High1.36
  • Day Low1.25
  • Prev Close1.34
  • 52 Week High7.13
  • 52 Week High Date06/26/23
  • 52 Week Low1.20
  • 52 Week Low Date02/08/24

Key Stats

  • Market Cap8.598M
  • Shares Out6.77M
  • 10 Day Average Volume1.21M
  • Dividend-
  • Dividend Yield-
  • Beta7.60
  • YTD % Change-27.01

KEY STATS

  • Open1.35
  • Day High1.36
  • Day Low1.25
  • Prev Close1.34
  • 52 Week High7.13
  • 52 Week High Date06/26/23
  • 52 Week Low1.20
  • 52 Week Low Date02/08/24
  • Market Cap8.598M
  • Shares Out6.77M
  • 10 Day Average Volume1.21M
  • Dividend-
  • Dividend Yield-
  • Beta7.60
  • YTD % Change-27.01

RATIOS/PROFITABILITY

  • EPS (TTM)-3.54
  • P/E (TTM)-0.36
  • Fwd P/E (NTM)-0.58
  • EBITDA (TTM)-15.055M
  • ROE (TTM)-105.41%
  • Revenue (TTM)145,799.994
  • Gross Margin (TTM)31.67%
  • Net Margin (TTM)-9,887.16%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date05/12/2024
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On BioRestorative Therapies Inc

 

Profile

MORE
BioRestorative Therapies, Inc. is engaged in developing therapeutic products and medical therapies using cell and tissue protocols, primarily involving adult stem cells. The Company has two core programs that relate to the treatment of disc/spine disease and metabolic disorders. Its lead cell therapy candidate, BRTX-100, is a product formulated from autologous (or a person's own) cultured mesenchymal stem cells collected from the patient's bone marrow. It has commenced a...
Lance Alstodt
Chairman of the Board, President, Chief Executive Officer
Robert Kristal
Chief Financial Officer
Robert Paccasassi
Vice President - Quality Assurance/Regulatory Compliance
Address
40 MARCUS DRIVE
Melville, NY
11747
United States